FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

New data suggests early risk from Vioxx

Tools

New data indicates that Vioxx may be most dangerous to patients three to four months after they start taking the medicine. Researchers had earlier estimated that the cardiovascular risks associated with Vioxx rose after 18 months of use, according to a report in The Wall Street Journal. The new analysis is based on a follow-up study of data gathered in earlier studies. Vioxx was removed from the market in 2004.

- read the CNN report on Vioxx

ALSO: A group of shareholders lawsuits claiming that Merck executives had violated their duties by hiding the health risk of Vioxx has been dismissed due to a procedural issue. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Merck   Vioxx   shareholders   lawsuits   cardiovascular risks